21.16 USD
▼-1.20-5.37%
盘后 21.84 +3.21%
2026-09-15
市值
$2.53B
市盈率
—
EPS
-2.14
股息率
—
52 周区间
21.08 – 42.21
成交量
1.73M
Beta
0.10
目标价
51.56
52W 低 21.0852W 高 42.21
价格走势
公司简介
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer’s disease. NewAmsterdam Pharma Company N.V. is headquartere...